Organon & Co. (BMV:OGN)

Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of MXN 45.99 billion. The enterprise value is 203.27 billion.

Market Cap	45.99B
Enterprise Value	203.27B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	259.96M
Shares Outstanding	n/a
Shares Change (YoY)	+1.17%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	258.73M

Valuation Ratios

The trailing PE ratio is 3.00 and the forward PE ratio is 2.49.

PE Ratio	3.00
Forward PE	2.49
PS Ratio	0.36
PB Ratio	4.15
P/TBV Ratio	n/a
P/FCF Ratio	2.90
P/OCF Ratio	2.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.15, with an EV/FCF ratio of 12.80.

EV / Earnings	13.26
EV / Sales	1.73
EV / EBITDA	6.15
EV / EBIT	7.72
EV / FCF	12.80

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 16.52.

Current Ratio	1.67
Quick Ratio	0.77
Debt / Equity	16.52
Debt / EBITDA	5.07
Debt / FCF	11.53
Interest Coverage	2.74

Financial Efficiency

Return on equity (ROE) is 254.24% and return on invested capital (ROIC) is 9.64%.

Return on Equity (ROE)	254.24%
Return on Assets (ROA)	7.03%
Return on Invested Capital (ROIC)	9.64%
Return on Capital Employed (ROCE)	13.36%
Revenue Per Employee	12.86M
Profits Per Employee	1.53M
Employee Count	10,000
Asset Turnover	0.50
Inventory Turnover	2.05

Taxes

Income Tax	-1.59B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.29%
50-Day Moving Average	174.11
200-Day Moving Average	278.34
Relative Strength Index (RSI)	44.82
Average Volume (20 Days)	9

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.83

Income Statement

In the last 12 months, Organon & Co. had revenue of MXN 128.64 billion and earned 15.33 billion in profits. Earnings per share was 58.81.

Revenue	128.64B
Gross Profit	73.74B
Operating Income	28.78B
Pretax Income	13.73B
Net Income	15.33B
EBITDA	34.83B
EBIT	28.78B
Earnings Per Share (EPS)	58.81

Balance Sheet

The company has 11.18 billion in cash and 183.05 billion in debt, giving a net cash position of -171.87 billion.

Cash & Cash Equivalents	11.18B
Total Debt	183.05B
Net Cash	-171.87B
Net Cash Per Share	n/a
Equity (Book Value)	11.08B
Book Value Per Share	42.95
Working Capital	35.89B

Cash Flow

In the last 12 months, operating cash flow was 19.17 billion and capital expenditures -3.29 billion, giving a free cash flow of 15.88 billion.

Operating Cash Flow	19.17B
Capital Expenditures	-3.29B
Free Cash Flow	15.88B
FCF Per Share	n/a

Margins

Gross margin is 57.32%, with operating and profit margins of 22.37% and 11.92%.

Gross Margin	57.32%
Operating Margin	22.37%
Pretax Margin	10.68%
Profit Margin	11.92%
EBITDA Margin	27.07%
EBIT Margin	22.37%
FCF Margin	12.35%

Dividends & Yields

This stock pays an annual dividend of 17.03, which amounts to a dividend yield of 9.34%.

Dividend Per Share	17.03
Dividend Yield	9.34%
Dividend Growth (YoY)	-11.28%
Years of Dividend Growth	1
Payout Ratio	39.73%
Buyback Yield	-1.17%
Shareholder Yield	8.18%
Earnings Yield	33.33%
FCF Yield	34.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	5